Drugs / docosahexaenoic acid ethyl ester
docosahexaenoic acid ethyl ester
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02708771 | Mar 2016 → Jun 2018 | heart failure | Hospital San Juan de la Cruz | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | docosahexaenoic acid ethyl ester | “Each capsule contains: 460 mg eicosapentaenoic acid ethyl ester and 380 mg docosahexaenoic acid ethyl ester.” NCT02708771 ↗ |
| Modality | Other / unclassified | “Polyunsaturated fatty acids omega-3” NCT02708771 ↗ |